Dalbavancin/Oritavancin for treatment of PJI Part 3

Om avsnittet

In the conclusion of this series on long-acting antibiotics, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they wrap up the conversation with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com

FOLLOW us on X @jointapproachor Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Om avsnittet

Fler avsnitt

Candidal PJI: Uncommon and Unforgettable, Part 2

Candidal PJI's: Uncommon and Unforgettable, Part 1

Does the "5-second" Rule Apply to Dropped Medical Objects in the OR?

Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry Part 2

Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry- Part 1

Lysins: A Next Generation Treatment Option for PJI? Part 2

Lysins: A Next Generation Treatment Option for PJI? Part 1

ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 2

ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 1

ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?” Part 2